HEXO — Hexo Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
- CA$38.72m
- CA$198.54m
- CA$191.10m
Annual balance sheet for Hexo, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS/A | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 245 | 140 | 184 | 67.5 | 83.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 14.9 | 48.3 | 36.2 | 51 | 50.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 277 | 312 | 306 | 694 | 272 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 54.3 | 259 | 285 | 394 | 286 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 335 | 879 | 693 | 1,312 | 681 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.1 | 52.7 | 82.5 | 504 | 335 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12.1 | 90.9 | 140 | 582 | 367 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 323 | 788 | 553 | 730 | 314 |
| Total Liabilities & Shareholders' Equity | 335 | 879 | 693 | 1,312 | 681 |
| Total Common Shares Outstanding |